We are live on
!
Find out more
CAC
Cowen and Company Portfolio holdings
AUM
$2.97B
1-Year Est. Return
105.26%
This Fund
S&P 500
This Quarter
Est. Return
+2.81%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$2.97B
AUM Growth
-$668M
(-18%)
Cap. Flow
+$51.1M
Cap. Flow
% of AUM
1.72%
Top 10 Holdings %
Top 10 Hldgs %
63.58%
Holding
795
New
186
Increased
196
Reduced
157
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$120M |
| 2 |
Eli Lilly
LLY
|
+$117M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$70.3M |
| 4 |
Amazon
AMZN
|
+$16.6M |
| 5 |
Palantir
PLTR
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$239M |
| 2 |
RNAM
Avidity Biosciences
RNAM
|
+$210M |
| 3 |
Apple
AAPL
|
+$183M |
| 4 |
Advanced Micro Devices
AMD
|
+$98.8M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$91.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.38% |
| 2 | Financials | 18.11% |
| 3 | Healthcare | 16.24% |
| 4 | Consumer Discretionary | 10.31% |
| 5 | Communication Services | 9.55% |
No holdings matched the selected filter criteria.
Similar funds
CIP
PWLP
FPCG
SI
BC
FTDI
CIM
PRO
Cowen and Company's Q3 2024 Portfolio in Review
As of Q3 2024, Cowen and Company held 795 positions worth $2.97B, down 18% from $3.64B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Cowen and Company's Q3 2024 filing shows 186 new, 196 increased, 157 reduced and 179 closed positions. Its largest new stake was Eli Lilly: 130,399 shares worth $116M. The largest sale was Meta Platforms (Facebook), an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.
- Cowen and Company's largest Q3 2024 buy was Eli Lilly: 130,399 shares worth $116M.
- Cowen and Company added most to Microsoft in Q3 2024, an estimated $120M increase.
- Cowen and Company's biggest Q3 2024 reduction was Meta Platforms (Facebook), cutting an estimated $239M.
- Cowen and Company fully exited Avidity Biosciences in Q3 2024, selling an estimated $210M.
- Cowen and Company's ten largest holdings make up 64% of its $2.97B portfolio in Q3 2024.
- Cowen and Company opened 186 new positions and closed 179 in Q3 2024.
- Cowen and Company's portfolio value fell 18% quarter-over-quarter to $2.97B.
Based on Cowen and Company's 13F filing for Q3 2024, filed 12 Nov 2024.